Taysha Gene Therapies TSHA
$3.72 −$0.05 (-1.33%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $3.71 -0.27%
Open$3.67
Prev close$3.77
Day range$3.60 – $3.80
Volume3.15M
Market cap$1.21B
P/E (TTM)–
Dividend yield–
Analyst view
ConsensusBuy
Analysts4
Average target$14.33+285.2% vs. price
- Buy 100%
Low $12.00Now $3.72Avg $14.33High $17.00
Recent rating changes
The last 20 actions on file set price targets from $10.00 to $19.00, averaging $13.39.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 13 Nov 2026 | CCORF | BUY | $17.00 |
| 13 Nov 2026 | BMO Capital | BUY | $14.00 |
| 16 Oct 2026 | Piper Sandler | BUY | $12.00 |
| 17 Sep 2026 | Wolfe Research | BUY | – |
| 14 Aug 2026 | BofA Securities | BUY | – |
| 12 Aug 2026 | Piper Sandler | BUY | $12.00 |
| 12 Aug 2026 | Needham | BUY | $12.00 |
| 11 Aug 2026 | Cantor Fitzgerald | BUY | $19.00 |
| 11 Aug 2026 | CCORF | BUY | $17.00 |
| 11 Aug 2026 | Goldman Sachs | BUY | $13.00 |
| 20 Jul 2026 | Goldman Sachs | BUY | $13.00 |
| 1 Jul 2026 | Needham | BUY | $12.00 |
| 30 Jun 2026 | Piper Sandler | BUY | $12.00 |
| 30 Jun 2026 | Baird | BUY | $15.00 |
| 30 Jun 2026 | Needham | BUY | $12.00 |
| 30 Jun 2026 | BMO Capital | BUY | $14.00 |
| 23 Jun 2026 | Citizens JMP | BUY | $11.00 |
| 23 Jun 2026 | BMO Capital | BUY | $14.00 |
| 22 Jun 2026 | BofA Securities | BUY | $10.00 |
| 22 Jun 2026 | Needham | BUY | $12.00 |
No comments yet — be the first to weigh in on TSHA.
Sign in to join the discussion.